February 19, 2024
Active Pharma's Toyama Yatsuo Plant Tokyo-based Active Pharma, which received a business improvement order earlier this month, was punished in part for shipping APIs of eszopiclone and sarpogrelate by concealing erroneous or inappropriate manufacturing procedures, a source close to the...read more